ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM21 | ADAM metallopeptidase domain 21 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM30 | ADAM metallopeptidase domain 30 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS19 | ADAM metallopeptidase with thrombospondin type 1 motif, 19 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Mixed |
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif, 20 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Not detected |
ADAMTS3 | ADAM metallopeptidase with thrombospondin type 1 motif, 3 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS6 | ADAM metallopeptidase with thrombospondin type 1 motif, 6 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Mixed |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL3 | ADAMTS-like 3 | Predicted secreted proteins
| | | | | Mixed |
ADCK1 | AarF domain containing kinase 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ADCK2 | AarF domain containing kinase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ADCK5 | AarF domain containing kinase 5 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ADCY7 | Adenylate cyclase 7 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ADGB | Androglobin | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ADIG | Adipogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADPRHL1 | ADP-ribosylhydrolase like 1 | Predicted intracellular proteins
| | | | | Group enriched |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFMID | Arylformamidase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
AGAP10 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 10 | Predicted intracellular proteins
| | | | | Expressed in all |
AGAP4 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 | Predicted intracellular proteins
| | | | | Expressed in all |
AGAP5 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 5 | Predicted intracellular proteins
| | | | | Mixed |
AGAP6 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 | Predicted intracellular proteins
| | | | | Expressed in all |
AGBL3 | ATP/GTP binding protein-like 3 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AGBL4 | ATP/GTP binding protein-like 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AGBL5 | ATP/GTP binding protein-like 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AHRR | Aryl-hydrocarbon receptor repressor | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
AHSA2 | AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) | Predicted intracellular proteins
| | | | | Expressed in all |
AIM1L | Absent in melanoma 1-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKNAD1 | AKNA domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
AKR1B15 | Aldo-keto reductase family 1, member B15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | Predicted membrane proteins
| | | | | Mixed |
ALG1L | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALLC | Allantoicase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK3 | Alpha-kinase 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ALS2CR11 | Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 | Predicted intracellular proteins
| | | | | Tissue enriched |
AMDHD1 | Amidohydrolase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
AMIGO3 | Adhesion molecule with Ig-like domain 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
AMN1 | Antagonist of mitotic exit network 1 homolog (S. cerevisiae) | Predicted intracellular proteins
| | | | | Expressed in all |